CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 189 enrolled
Drug / intervention
Omnipod 5 Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05923827
NCT05923827N/ACompleted
CompareCT.gov

Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)

Insulet Corporation·interventional·Posted Jun 28, 2023·Updated Apr 14, 2026

In Brief

A clinical study evaluating Omnipod 5 System for Diabetes Mellitus, Type 1. Completed, enrolled 189 participants across 19 sites in 3 countries.

Detailed Summary

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous glucose monitor compared to Multiple Daily Injections (MDI) along with the FreeStyle Libre 2 continuous glucose monitor in children and adults with type 1 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesBelgium, France, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJun 28, 2023
Enrollment StartSep 11, 2023
Primary CompletionAug 16, 2024
Study CompletionFeb 12, 2026
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.0 years ago

Interventions

Omnipod 5 Systemdevice

The Omnipod 5 system is a tubeless patch pump that receives glucose values and trend data from the glucose sensor every 5 minutes, automatically calculates insulin dose, and sends delivery commands to the Pod for the delivery of insulin.